TGA Approval

LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe (342250)

ARTG ID

342250

ARTG Name

LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

September 14, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/e4d04893301dd6c13117cb4530b974cb.pdf

https://medical-cdn.nocode.com/drug_tga/138f08c1578b3f077645371bf7718124.pdf

Ingredient Name

inclisiran

Empowering clinical research with data-driven insights and AI-powered tools.

LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe (342250) - TGA 批准文号 | MedPath